Associated Papers
Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine.
Gallardo-Cóndor J et al.
Therapeutics and Clinical Risk Management, 2023
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
31159795 (PubMed )
Supplement: 12920_2019_527_MOESM1_ESM.xlsx › Table_S6
A new thiopurine s-methyltransferase haplotype associated with intolerance to azathioprine.
Colleoni L et al.
Journal of Clinical Pharmacology, 2013
Comprehensive screening of the thiopurine methyltransferase polymorphisms by denaturing high-performance liquid chromatography.
Udaka T et al.
Genetic Testing, 2005
Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
Schwab M et al.
Pharmacogenetics, 2002
High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC.
Schaeffeler E et al.
Clinical Chemistry, 2001
Recent advances in the pharmacogenomics of thiopurine methyltransferase.
Coulthard SA et al.
The Pharmacogenomics Journal, 2001
Screening of thiopurine S-methyltransferase mutations by horizontal conformation-sensitive gel electrophoresis.
Alves S et al.
Human Mutation, 2000
Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms.
Otterness D et al.
Clinical Pharmacology and Therapeutics, 1997
Select a paper to view details